Guys, a with the options, the thing to watch with the next...

Guys, a with the options, the thing to watch with the next quarterly is confirmation they lodged 510k with the FDA for airsonea. If they didn't, it could be tight as to whether it will hit the shelves in US inside Q2 2014, (based on 120 day turnaround, and time to prepare for the launch). Plus the real risk they don't get OTC first try. Under any of these scenarios, I can see the options being more heavily discounted; especially if heads fall further. I personally don't think the risk/reward for holding options makes sense going into 2014. Just my thoughts...

Otherwise, MT came back and would not be drawn at all on his resignation, which I thought was odd. He was also not willing to comment either on Sonosentery due to the fact he was no longer with the company, which I thought was fair enough. Jerry Korten did not write back. MT thought Washer was best POC for shareholer relations going forwards.